Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
38.65 HKD | -4.57% | -6.42% | -51.35% |
May. 16 | WuXi AppTec Denies Being a Security Threat to US | MT |
May. 16 | HONG KONG SHARES OF WUXI APPTEC SET TO OPEN DOWN 2.1% AFTER US H… | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Biotechnology & Medical Research
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-51.35% | 17.62B | - | ||
+9.58% | 115B | B+ | ||
+12.41% | 107B | B+ | ||
-3.46% | 21.6B | B | ||
-12.38% | 22.31B | B+ | ||
-6.77% | 19.19B | A- | ||
-3.35% | 18.23B | B | ||
+7.51% | 14.26B | C+ | ||
+35.67% | 12.37B | C+ | ||
-24.50% | 8.28B | D |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 603259 Stock
- 2359 Stock
- Ratings WuXi AppTec Co., Ltd.